Princeton-Led Group Develops Cas13 SARS-CoV-2 Assay for Point-of-Care Use
The test can be prepared in a lateral flow format, requires no additional instruments, and can be run in at-home settings.
Stay updated with breaking news from Streamlined Highlighting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The test can be prepared in a lateral flow format, requires no additional instruments, and can be run in at-home settings.
GEN revisits selected IMED 2021—the International Meeting on Emerging Diseases and Surveillance— presentations that were delivered by speakers from North America, Africa, and Europe.
Now, a new study published on the medRxiv* preprint server describes and benchmarks SHINEv2, a Cas13-based nucleic acid diagnostic for SARS-CoV-2 detection. SHINEv2 combines temperature sample processing and lyophilized reagents to simplify the test procedure and assay distribution immensely.